IGFBP3 also failed to discriminate cases from controls, although was decreased in case samples that went on to be diagnosed with HER2+ breast cancer where there was a strong association for the <1.15 years to diagnosis group (Table 4B; Figure 1B). This evidence concerns the gene IGFBP3 and breast carcinoma.